Study

EORTC-1754

Study to determine the aetiology of chlormethine gel induced-skin drug reaction in early stage mycosis fungoides cutaneous T cell lymphoma (MF-CTCL)

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 29-Mar-2022
Date Step1 close: 23-Mar-2023

Data management at EORTC

Yes

Design

Phase 2
Not randomized / N.A.

Targeted Sample size

EORTC Groups: 100

Treatment

Study Staff

Type of cancer

Participating groups

Protocol summary

http://clinicaltrials.gov/study/NCT04218825

NCT number

NCT04218825

EudraCT

2019-004891-20